Remedi introduces best handheld X-ray solution to India
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Getinge has a strong market share in India within several product segments
Women of all ages will get round-the-clock access to comprehensive treatment
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Subscribe To Our Newsletter & Stay Updated